Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Antioxidant protective effects of lactitol against endotoxemia in patients with chronic viral hepatitis.

Chen C, Yu X, Lu H, Xiao D, Mao W, Li L.

Mol Med Rep. 2013 Feb;7(2):401-5. doi: 10.3892/mmr.2012.1188. Epub 2012 Nov 16.

PMID:
23165913
2.

Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis.

Chen C, Li L, Wu Z, Chen H, Fu S.

J Infect. 2007 Jan;54(1):98-102. Epub 2006 Oct 16.

PMID:
17049992
3.
4.

Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure.

Lee KC, Yang YY, Wang YW, Lee FY, Loong CC, Hou MC, Lin HC, Lee SD.

Dig Dis Sci. 2010 Jul;55(7):2077-85. doi: 10.1007/s10620-009-0990-2. Epub 2009 Oct 14.

PMID:
19826951
5.

Changes in intestinal microflora in patients with chronic severe hepatitis.

Li L, Wu Z, Ma W, Yu Y, Chen Y.

Chin Med J (Engl). 2001 Aug;114(8):869-72.

PMID:
11780370
6.
7.

Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B.

Demirdag K, Yilmaz S, Ozdarendeli A, Ozden M, Kalkan A, Kilic SS.

Hepatogastroenterology. 2003 May-Jun;50(51):766-70.

PMID:
12828081
8.

Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation.

Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, Hsu WC, Huang CC, Wang SS, Lo KJ.

J Hepatol. 1995 Feb;22(2):165-72.

PMID:
7790704
9.

The role of the gut barrier function in the pathophysiology of viral liver cirrhosis.

Choi Y, Jeon WK, Hwang SJ, Kim BI, Sohn CI, Park DI, Cho YK, Kim HJ, Park JH.

Hepatogastroenterology. 2011 Jul-Aug;58(109):1244-7. doi: 10.5754/hge10338.

PMID:
21937387
10.

Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients.

Riggio O, Varriale M, Testore GP, Di Rosa R, Di Rosa E, Merli M, Romiti A, Candiani C, Capocaccia L.

J Clin Gastroenterol. 1990 Aug;12(4):433-6.

PMID:
2398251
11.

[Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].

Pár A, Róth E, Rumi G Jr, Kovács Z, Nemes J, Mózsik G.

Orv Hetil. 2000 Jul 23;141(30):1655-9. Hungarian.

PMID:
10962902
12.

Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemia-reperfusion injury.

Xing HC, Li LJ, Xu KJ, Shen T, Chen YB, Sheng JF, Chen Y, Fu SZ, Chen CL, Wang JG, Yan D, Dai FW, Zheng SS.

J Gastroenterol Hepatol. 2006 Apr;21(4):647-56.

PMID:
16677148
13.

Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration.

Evereklioglu C, Er H, Doganay S, Cekmen M, Turkoz Y, Otlu B, Ozerol E.

Doc Ophthalmol. 2003 Mar;106(2):129-36.

PMID:
12678277
14.

Effects of Salvia miltiorrhiza on intestinal microflora in rats with ischemia/reperfusion liver injury.

Xing HC, Li LJ, Xu KJ, Shen T, Chen YB, Chen Y, Fu SZ, Sheng JF, Chen CL, Wang JG, Yan D, Dai FW, Sha XY.

Hepatobiliary Pancreat Dis Int. 2005 May;4(2):274-80.

15.

Experimental acute alcohol pancreatitis-related liver damage and endotoxemia: synbiotics but not metronidazole have a protective effect.

Marotta F, Barreto R, Wu CC, Naito Y, Gelosa F, Lorenzetti A, Yoshioka M, Fesce E.

Chin J Dig Dis. 2005;6(4):193-7.

PMID:
16246229
16.

The protective effect of melatonin on nicotine-induced myocardial injury in newborn rats whose mothers received nicotine.

Baykan A, Narin N, Narin F, Akgün H, Yavaşcan S, Saraymen R.

Anadolu Kardiyol Derg. 2008 Aug;8(4):243-8.

17.

Effects of intestinal endotoxemia on pathogenesis of liver injury induced by thioacetamide.

Liu L, Han D, Ren D.

Zhonghua Gan Zang Bing Za Zhi. 2000 Jun;8(3):174-5. Chinese.

PMID:
10880171
18.

Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure.

Wang W, Jittikanont S, Falk SA, Li P, Feng L, Gengaro PE, Poole BD, Bowler RP, Day BJ, Crapo JD, Schrier RW.

Am J Physiol Renal Physiol. 2003 Mar;284(3):F532-7.

19.
20.

Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats.

Koc A, Duru M, Ciralik H, Akcan R, Sogut S.

Mol Cell Biochem. 2005 Oct;278(1-2):79-84.

PMID:
16180092

Supplemental Content

Support Center